source
- Flagship’s ProFound Therapeutics secures up to $35 M from Gates Foundation to discover preeclampsia drug targetsFlagship Pioneering’s ProFound Therapeutics has entered a new partnership with the Gates Foundation that could provide up to $35 million for research. The agreement includes an initial $20 million…
- Early Inclusion of China Boosts Global Biotech Clinical Development EfficiencyMany global biotech firms still treat China as a later-stage commercial market, adding it only after key development decisions. This practice often forces costly bridging studies, extends timelines…